ARCHIVES

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

This article is from The Cancer Letter archive.

Vol. 30 No. 9 | September 28, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Friends of Cancer Research Honor Specter; Dole Tapes Announcement For CaP CURE

January 24, 1997

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

In Brief: DCBD Board Adds Concept Review To Duties, Rabson Seeks Four Additional Member

September 19, 1980

Lymphoma Foundation Offers Research Grants

June 28, 1996

In Brief: Murphy To Head Pediatric Oncology Group; DeVita To Receive ACCC Research Award

May 1, 1992

Zeneca Says NSABP Was Tardy In Reporting Uterine Cancer Deaths

June 24, 1994